Zeidler, J., Mittendorf, T., Müller, R., & von Kempis, J. (2012). Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: Dosing patterns and related costs in Switzerland from a payers perspective. Health Economics Review, 2(1), 1. https://doi.org/10.1186/2191-1991-2-20
Παραπομπή σε μορφή Chicago (17η εκδ.)Zeidler, Jan, Thomas Mittendorf, Rüdiger Müller, και Johannes von Kempis. "Biologic TNF Inhibiting Agents for Treatment of Inflammatory Rheumatic Diseases: Dosing Patterns and Related Costs in Switzerland from a Payers Perspective." Health Economics Review 2, no. 1 (2012): 1. https://doi.org/10.1186/2191-1991-2-20.
Παραπομπή σε μορφή MLA (9th εκδ.)Zeidler, Jan, et al. "Biologic TNF Inhibiting Agents for Treatment of Inflammatory Rheumatic Diseases: Dosing Patterns and Related Costs in Switzerland from a Payers Perspective." Health Economics Review, vol. 2, no. 1, 2012, p. 1, https://doi.org/10.1186/2191-1991-2-20.